igf-1 lr3 fda approval status LR3: Nasal Spray vs. Subcutaneous Injection Comparison Buy IGF-1 LR3 1mg |
Description
1 ml/kg per day i.v.) 5 min before ASA administration (30 mg/kg per day, by oral gavage)
Novel natural product therapeutics targeting both inflammation and cancer
Images were analyzed with ImageLab (Bio-rad) and ImageJ software
Although in healthy cells it is crucial for the removal and detoxification of carcinogens, elevated GSH levels in tumor cells are associated with tumor progression and increased resistance to chemotherapeutic drugs
